Robert Damoiseaux
About Robert Damoiseaux
Robert Damoiseaux is a co-founder of Forcyte, a professor at UCLA, and an expert in drug discovery and molecular screening.
Robert Damoiseaux Career at GNF
Robert Damoiseaux previously worked at the Genomics Institute of the Novartis Research Foundation (GNF). At GNF, Damoiseaux contributed to various research and development initiatives, utilizing his expertise to advance the organization's genomics and drug discovery efforts. His role there leveraged both his deep knowledge in molecular pharmacology and his hands-on experience with high-throughput screening methodologies.
Robert Damoiseaux Molecular Screening Shared Resource
Robert Damoiseaux is the creator and director of the Molecular Screening Shared Resource. This facility provides advanced screening technologies and expertise essential for modern molecular and drug discovery research. Under his leadership, the resource aids in the identification and validation of new drug candidates through automated high-throughput screening, significantly advancing research in molecular pharmacology.
Robert Damoiseaux Role at Forcyte
Robert Damoiseaux plays a pivotal role at Forcyte, providing automation firepower and drug discovery expertise. His contributions enable Forcyte's efforts at scale, leveraging his background in molecular and medical pharmacology. His involvement ensures that Forcyte's drug discovery processes are efficient and effective, utilizing cutting-edge technologies and methodologies.
Robert Damoiseaux Professor at UCLA
Robert Damoiseaux is a Professor of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA). In this role, he teaches and mentors students while conducting research in molecular pharmacology. His academic work includes developing new methods and technologies for drug discovery, contributing to the field's advancement through both education and innovation.